APA (7th ed.) Citation

Kuijpers, T., Spencer, F. A., Siemieniuk, R. A. C., Vandvik, P. O., Otto, C. M., Lytvyn, L., . . . Guyatt, G. (2018). Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ (Online), 362, k2515. https://doi.org/10.1136/bmj.k2515

Chicago Style (17th ed.) Citation

Kuijpers, Ton, et al. "Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke? A Clinical Practice Guideline." BMJ (Online) 362 (2018): k2515. https://doi.org/10.1136/bmj.k2515.

MLA (9th ed.) Citation

Kuijpers, Ton, et al. "Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke? A Clinical Practice Guideline." BMJ (Online), vol. 362, 2018, p. k2515, https://doi.org/10.1136/bmj.k2515.